Related Experiment Video

Updated: Aug 21, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Molting, enzymes and new targets for chemotherapy of Onchocerca volvulus

S Lustigman1

  • 1Department of Virology and Parasitology, The Lindsley F. Kimball Research Institute o f the New York Blood Center, 310 East 67th Street, New York, NY 10021, USA.

Parasitology Today (Personal Ed.)
|August 1, 1993
PubMed

Insights

Parasitic nematodes like Onchocerca volvulus mature in hosts, not multiply. Key enzymes crucial for larval development are identified as potential therapeutic targets for treating infections.

Area of Science:

  • Parasitology
  • Molecular Biology
  • Drug Discovery

Background:

  • Parasitic nematodes, such as Onchocerca volvulus, undergo essential development stages within a definitive host.
  • These nematodes do not replicate but mature, molt, and grow before focusing on reproduction.

Purpose of the Study:

  • To review critical metabolic enzymes vital for the larval development of Onchocerca volvulus.
  • To identify these enzymes as potential targets for novel therapeutic interventions.

Main Methods:

  • Literature review focusing on metabolic pathways in parasitic nematode development.
  • Analysis of enzyme functions essential for Onchocerca volvulus larval stages.

Main Results:

  • Several key metabolic enzymes have been identified as indispensable for Onchocerca volvulus larval maturation.
  • These enzymes play crucial roles in the parasite's growth and development within the host.

Conclusions:

  • Targeting these essential metabolic enzymes presents a promising strategy for developing new treatments against Onchocerca volvulus infections.
  • Understanding these parasitic enzymes can lead to effective anti-parasitic drug development.

More Related Videos

Transient Transduction of the Strobilated Forms of Echinococcus granulosus13:25

Transient Transduction of the Strobilated Forms of Echinococcus granulosus

Published on: September 16, 2022

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...